• By ICR Secretariat
  • Posted Thursday, April 15, 2021

Researchers lay out hypothesis for rare side effect linked to AstraZeneca vaccine

https://www.biopharmadive.com/news/astrazeneca-vaccine-blood-clots-hypothesis-heparin-hit/598110/

Researchers in Germany, Norway and Austria have put forward a hypothesis for why in some very rare cases the coronavirus vaccine developed by AstraZeneca and the University of Oxford seems to trigger an abnormal and potentially life-threatening combination of blood clotting and low platelet counts.